In 2025, Carrot partnered with Oura and Dexcom to combine sleep, stress, activity and glucose data with clinical guidance for members in Carrot's metabolic fertility program
Understanding this mechanism is essential for anyone considering peptides for visceral fat reduction
If they detect any problems with your kidneys, they may stop your treatment with the drug
J Acquir Immune Defic Syndr 89(Suppl 1):S34S46 Bandera A et al (2018) Altered gut microbiome composition in HIV infection: causes, effects and potential intervention
Quick Answer: GLP-1 medications show clinically meaningful average weight loss in large-scale peer-reviewed trials - approximately 14.9% for semaglutide (STEP 1) and up to 20.9% for tirzepatide (SURMOUNT-1) under trial conditions
We celebrate your successes and make any necessary adjustments to your GLP-1 Peptide treatment plan, ensuring your progress is consistent and sustainable